Scalp Cooling and Chemotherapy-Induced Alopecia: Evaluating Cost-Effectiveness and Insurance Coverage

    January 2026 in “ Dermatology Online Journal
    Lauren M. McGrath, Alice L. Mikulinsky, Steven Feldman
    TLDR Scalp cooling is cost-effective for reducing hair loss from chemotherapy and should be covered by insurance.
    Scalp cooling, a method to reduce chemotherapy-induced alopecia (CIA), is cost-effective compared to dermatologic management strategies, with an incremental cost-effectiveness ratio (ICER) of $3,050 per QALY versus dermatologic management plus minoxidil and –$2,950 per QALY versus dermatologic management plus minoxidil and platelet-rich plasma. These ICERs are below common U.S. willingness-to-pay thresholds, suggesting that scalp cooling is a financially viable supportive care intervention. The study advocates for routine insurance coverage of scalp cooling to improve access and support patients' quality of life during chemotherapy.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results